US20070227931A1 - Child-Resistant Wallet Package for Dosage Forms - Google Patents
Child-Resistant Wallet Package for Dosage Forms Download PDFInfo
- Publication number
- US20070227931A1 US20070227931A1 US11/688,966 US68896607A US2007227931A1 US 20070227931 A1 US20070227931 A1 US 20070227931A1 US 68896607 A US68896607 A US 68896607A US 2007227931 A1 US2007227931 A1 US 2007227931A1
- Authority
- US
- United States
- Prior art keywords
- wallet
- blister
- panel
- package
- blister sheet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2200/00—General characteristics or adaptations
- A61J2200/30—Compliance analysis for taking medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/30—Printed labels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2215/00—Child-proof means
- B65D2215/04—Child-proof means requiring the combination of different actions in succession
Definitions
- the present invention relates to wallet packaging for dosage forms, such as dosage forms for medicaments, herbal extracts, vitamins, or the like.
- Wallet packages for dosage forms have gained popularity as vehicles for delivering medicaments and the like to consumers.
- blister packs in which dosage units can be pushed through a retaining barrier are adhered between layers of cardboard or the like.
- the dosage units can be viewed through holes in one of the sandwiching layers, with this layer typically having language that helps the user comply with dosage requirements, dosage schedule or the like.
- To access a dosage unit it may be pushed through the back barrier and a corresponding hole in the other sandwiching layer.
- Other panels of cardboard allow the sandwiching layers to be folded into the wallet, and provide surfaces on which to provide promotional material, compliance information, safety information, or the like.
- the invention relates to a wallet package for presenting blister sheets comprising: (1) a first wallet panel with a width and height (without limitation as to shape); (2) a blister sheet comprising dosage forms enclosed between a first side material and a second side material, the second side material having one or more blister barriers, wherein the blister sheet is secured to the first wallet panel such that (i) the dosage forms and the corresponding area of the blister barrier(s) can nonetheless be pulled away from the first wallet panel, or (ii) an edge of the blister sheet can be pulled sufficiently away from the first wallet panel so that blister access devices for said blister barrier(s) can be accessed; and (3) additional wallet panels with a width and height hingably connected, among themselves and the first wallet panel, such that when folded to a fold position a resulting width and height of the folded wallet package is about the width and height of a largest said wallet panel, wherein the wallet package can be reversibly folded to the fold position to cover the blister sheet, and reversibly unfolded to uncover the blister sheet.
- FIGS. 1A-1F illustrate various views of a wallet package of the invention.
- FIG. 2 shows another embodiment of a wallet package of the invention.
- FIGS. 3A-3C illustrate various views of a wallet package of the invention.
- FIG. 4 shows another embodiment of a wallet package of the invention.
- FIG. 5 shows another embodiment of a wallet package of the invention.
- FIG. 6 shows another embodiment of a wallet package of the invention.
- FIG. 7 shows another embodiment of a wallet package of the invention.
- FIGS. 8A and 8B show another embodiment of a wallet package of the invention.
- FIGS. 9-11 shows further embodiments of wallet package of the invention.
- FIGS. 12 and 13 show a wallet packages.
- the wallet package can be arranged with blister sheets secured face down on a panel, or face up.
- the face down embodiments are illustrated first.
- FIG. 1 illustrates an embodiment of the invention utilizing wallet package 10 with four panels and three folds.
- a wide variety of fold sequences, layouts of panels, and numbers of panels can be used.
- Each illustrated exemplary panel has a first and second side (sides a and b, respectively).
- the first sides, 1 a , 2 a , 3 a and 4 a can be seen in FIG. 1A .
- Panel side 4 a has cutouts 11 (as exemplified, 2 rows of 4)
- the dotted box illustrates where blister sheet 20 , exemplified in FIG. 1B , is fitted.
- Blister sheet 20 turned over from the orientation illustrated, is fitted corner a to corner a, corner b to corner b, and so on, such that protrusions 22 (see FIG. 1C ) fit into cutouts 11 .
- the blister sheet has one or more backing layers of sufficient strength that a dosage unit (i) cannot be conveniently pushed through the backing layer(s) without peeling off some or all of at least one of the backing layers or (ii) can only be pushed through with a force sufficient to provide child-resistance.
- the backing layers are made up of a vapor barrier 21 B (e.g., foil), and a reinforcing layer 21 C. Reinforcing layer 21 C can be layered against (such as adhered to) vapor barrier 21 B, and can be peeled away from outer layer 21 A with or without all or part of the underlying vapor barrier 21 B.
- Outer layer 21 may or may not be transparent.
- the layers (of the backing layers) adapted to be peeled away are typically strong enough to not tear (except along perforations, cuts or other deliberate weakened structures) during the peeling process.
- These layers can be, for example, polymer-reinforced paper, polymer sheets, and the like.
- FIG. 1A show illustrative fold directions.
- Illustrated fold 1 D shows the fold of first side 1 a , onto first side 2 a , to yield the folded view of FIG. 1D , where, as a result of the fold, second side 1 b is face up.
- blister sheet 20 is shown adhered in place on first side 4 a , with its back side showing.
- the dark arrows illustrate positions for barrier access devices (defined below). Lines 24 can be perforations, cuts, or other weakenings in the reinforcing layer 21 C, such that any given blister barrier (defined below) is isolated to one dosage unit (or designated set of dosage units if appropriate).
- lines 24 can simply be boundaries between areas (again blister barriers) corresponding to dosage units (or sets of dosage units), and may have no physical presence on the blister sheet. Perforations can be through all layers of the blister sheet. Blister access devices, if present, can be located in any number of locations on the blister sheet. Perforations or cuts of lines 24 , for example, can be deeper at the barrier access devices to facilitate manual access.
- First and second reusable closures 17 A and 17 B allow the wallet device to be stably but releasably closed to enclose the back side of blister sheet 20 .
- Fold 1 E yields the view of FIG. 1E , where second side 4 b can include compliance assistance printing.
- First and second reusable closures 12 A and 12 B allow the wallet package 10 to be releasably held in a closed position.
- Fold 1 F yields the view of FIG. 1F , where second side 2 b includes printing of illustrative marketing information.
- the reusable closures can be of a wide variety known in the art, including reclosable glue seals (in which case one of closures of a pair ⁇ 12 A or 12 B, or 17 A or 17 B ⁇ is simply wallet material suitable for accepting the glue seal provided by the other closure), hook and loop closures such as VelcroTM, snaps, buttons, tuck and fit, and the like.
- Closures can be tapes or straps that partially or fully wrap around the folded wallet package.
- closures can be label closures (as known in the art) which can be reclosable and/or tamper evident.
- FIG. 2 shows an illustrative wallet package 30 with cutouts 31 , that uses an alternative fold pattern (from among the many available).
- the various panels of a wallet package can be used to provide printing with marketing, dosage, warnings, and the like.
- Booklets can be securely or releasably affixed to a panel.
- a product insert such as one required by a regulatory agency, can be so secured or affixed.
- secured or affixed can be a booklet that provides compliance assistance, such as a generic calendar with checkoffs, or the like.
- FIG. 3 shows an exemplary embodiment of a wallet package 50 in which blister sheet 60 can, in part, be folded away from panel 4 , for example along optional hinges 65 , thereby allowing greater manual access to the barrier access devices.
- FIG. 3B shows the two illustrated hinges 65 being used, and FIG. 3C shows just one such hinge engaged. In the absence of hinge structure, the dosage units can still be drawn away from panel 4 .
- Protrusions 62 are illustrated as protruding through panel 4 , though this can vary with embodiments.
- the blister sheet can be secured to panel 4 at, for example, contact surface 66 . Securing can be by a number of methods, such as adhesive methods, stitching, stapling, riveting, or the like.
- Optional closure-facilitating area 5 illustrates extra spine material used to facilitate one illustrative pattern for folding the panels. If panel 4 b provides compliance assistance printing, then the presence or absence of dosage units aligned with the compliance information can be apparent by looking through the cutouts.
- the child-resistant opening mechanism By pulling the dosage units away from panel 4 , the child-resistant opening mechanism can be more readily accessed. For example, blister access devices (defined below) located along an outer edge (pulled away from panel 4 ) can be accessed and engaged more easily. If a scissors or the like are needed to initiate a tear, pulling away allows access for a cut, and for any subsequent tear. Or, perforations can allow individual dosage units (or sets of dosage units) to be torn off, as facilitated by pulling away form panel 4 , and then the child-resistant opening mechanism can be operated.
- blister access devices defined below located along an outer edge (pulled away from panel 4 ) can be accessed and engaged more easily. If a scissors or the like are needed to initiate a tear, pulling away allows access for a cut, and for any subsequent tear. Or, perforations can allow individual dosage units (or sets of dosage units) to be torn off, as facilitated by pulling away form panel 4 , and then the child-resistant opening mechanism can be operated.
- FIG. 4 shows one of many other folding sequences or patterns for wallet package 70 , which is otherwise analogous to wallet package 50 (with folds 85 and protrusions 82 ). Fold A, in this exemplification, is conducted before fold B.
- Hinges such as hinges 65 or 85
- hinges 65 or 85 can be, for example, fold lines, where folding can be facilitated by methods known in the art, such as perforation along the fold line, compression along the fold line, heat with compression, pre-folding, or the like.
- the hinges can be designed to bias, to some extent, the blister pack tending to return to a flat aspect (ignoring the protrusions), so as to facilitate closing the wallet package.
- FIG. 5 shows a wallet package 90 in which the contact surface 106 is to one side of the blister sheet, and optional hinge 105 is on the same side.
- the contact surface can be on any side, such that the can pulled up from the right (as here), left, top or bottom (or still other orientations depending upon the blister sheet geometry, and the like).
- the hinge can be formed for example by wallet panel material, such as folds in the wallet panel. For example, supposing that contact surface 106 is on the left, top or bottom, a portion of wallet panel can extend to the corresponding left, top or bottom, connected by a hinge (such as a crease). The extended portion can fold over, and be adhered to, the contact surface, in which case the blister sheet 100 need not be hinged—while preserving all the function of wallet package 90 (or similar designs such as wallet package 230 ).
- Lines 104 A and 104 B are typically to the other side from the contact surface (here, on the right side). Italicized numbers 1 through 8 illustrate an optional order of usage for the dosage units. After dosage units 1-4 have been used, in some embodiments line 104 B allows the used portion of the blister sheet to be torn away, to provide greater access to the barrier access devices for dosage units 5-8. It will be recognized that the same multiple rows, and tearing away used rows, can be used with butterfly designs such as found in FIG. 3 .
- Shaded areas 108 A, 108 B, 108 C, 108 D are optional areas under the blister sheet that are secured to panel 4 with reclosable glue seals.
- FIG. 6 illustrates that nonlinear design elements can be incorporated into the presentation of dosage forms (wallet package 110 , hinges 125 , lines 124 , protrusions 122 ).
- FIG. 7 illustrates wallet package 130 , with lines 144 .
- the blister sheet 140 can be secured over various areas, such as contact surface 146 A, contact surface 146 B, or contact surface 146 C. Even if the secured area is relatively close to the barrier access devices, some separation allows more room for a users' fingers to manipulate the barrier access devices, with less interference from panel 4 .
- wallet package 210 has blister sheet 220 , optional hinge 225 , contact surface 226 , protrusions 222 and lines 224 .
- wallet package 230 has blister sheet 240 , optional hinge 245 , contact surface 246 , and optional reclosable glue seals 248 A, 248 B.
- FIG. 10 illustrates wallet package 250 .
- the blister sheet 260 can be secured over various areas, such as contact surface 266 A, contact surface 266 B, or contact surface 266 C.
- wallet package 270 is folded in one of the many alternative fold patterns.
- FIG. 12 illustrates a prior art design in which a blister sheet is adhered between panel 3 and panel 4 , such that there is no access to the back side of the blister sheet.
- drug form includes any solid form that is sufficiently self-cohesive to be presented in a blister sheet, and includes an amount of a material for delivery to a subject (such as by ingestion, as a suppository, as a lozenge, as a mucosal adherent, or the like).
- a “blister barrier” is a covering for one or more dosage units of which at least a portion must be peeled, torn, cut, or pushed through to allow a user of a dosage unit to conveniently, but in a child-resistant manner, access the dosage unit.
- Any blister barrier usable to provide child resistance in a blister sheet can be used in the invention.
- Child resistance is as recognized in the pharmaceutical industry (e.g., F1, F2, F3 levels of child resistance).
- a “blister access device” is any device used in a child-resistant blister sheet.
- Blister access devices can include, for example, a pull tab, a pull tab access by tearing perforations to allow peeling to reveal the pull tab, notches to facilitate tearing, and the like.
- a “wallet panel” is any panel made of a moderately stiff material allowing a wallet package to be reusably opened and closed over a useful lifetime. It will be recognized that, depending on dimension, the support provided by adhered components, and the like, that the stiffness required for making a useful wallet package can vary.
- a “subject” is any animal, including a human, for which it may be appropriate to delivery a dosage form.
Abstract
The invention relates to, among other things, a wallet package for presenting blister sheets comprising: (1) a first wallet panel with a width and height (without limitation as to shape); (2) a blister sheet comprising dosage forms enclosed between a first side material and a second side material, the second side material having one or more blister barriers, wherein the blister sheet is secured to the first wallet panel such that (i) the dosage forms and the corresponding area of the blister barrier(s) can nonetheless be pulled away from the first wallet panel, or (ii) an edge of the blister sheet can be pulled sufficiently away from the first wallet panel so that blister access devices for said blister barrier(s) can be accessed; and (3) additional wallet panels with a width and height hingably connected, among themselves and the first wallet panel, such that when folded to a fold position a resulting width and height of the folded wallet package is about the width and height of a largest said wallet panel, wherein the wallet package can be reversibly folded to the fold position to cover the blister sheet, and reversibly unfolded to uncover the blister sheet.
Description
- The present invention relates to wallet packaging for dosage forms, such as dosage forms for medicaments, herbal extracts, vitamins, or the like.
- Wallet packages for dosage forms have gained popularity as vehicles for delivering medicaments and the like to consumers. In these packages, blister packs in which dosage units can be pushed through a retaining barrier are adhered between layers of cardboard or the like. The dosage units can be viewed through holes in one of the sandwiching layers, with this layer typically having language that helps the user comply with dosage requirements, dosage schedule or the like. To access a dosage unit, it may be pushed through the back barrier and a corresponding hole in the other sandwiching layer. Other panels of cardboard allow the sandwiching layers to be folded into the wallet, and provide surfaces on which to provide promotional material, compliance information, safety information, or the like.
- What has not been available is a cost-effective means to have the advantages of a wallet package along with child resistance. Efforts to provide such child resistance have typically involved making mechanical puzzles or other barriers involving the packaging around the blister sheet. For example, one device must be opened, a cardboard button engaged, and the working part of the wallet device slid out, as illustrated in
FIG. 13 . In other devices wallet packaging material must be removed, as may be facilitated with pull tabs, or pushed through. It has not been recognized that child-resistance as embodied in the blister sheet itself can be effectively incorporated into wallet designs. - In one embodiment, the invention relates to a wallet package for presenting blister sheets comprising: (1) a first wallet panel with a width and height (without limitation as to shape); (2) a blister sheet comprising dosage forms enclosed between a first side material and a second side material, the second side material having one or more blister barriers, wherein the blister sheet is secured to the first wallet panel such that (i) the dosage forms and the corresponding area of the blister barrier(s) can nonetheless be pulled away from the first wallet panel, or (ii) an edge of the blister sheet can be pulled sufficiently away from the first wallet panel so that blister access devices for said blister barrier(s) can be accessed; and (3) additional wallet panels with a width and height hingably connected, among themselves and the first wallet panel, such that when folded to a fold position a resulting width and height of the folded wallet package is about the width and height of a largest said wallet panel, wherein the wallet package can be reversibly folded to the fold position to cover the blister sheet, and reversibly unfolded to uncover the blister sheet.
-
FIGS. 1A-1F illustrate various views of a wallet package of the invention. -
FIG. 2 shows another embodiment of a wallet package of the invention. -
FIGS. 3A-3C illustrate various views of a wallet package of the invention. -
FIG. 4 shows another embodiment of a wallet package of the invention. -
FIG. 5 shows another embodiment of a wallet package of the invention. -
FIG. 6 shows another embodiment of a wallet package of the invention. -
FIG. 7 shows another embodiment of a wallet package of the invention. -
FIGS. 8A and 8B show another embodiment of a wallet package of the invention. -
FIGS. 9-11 shows further embodiments of wallet package of the invention. -
FIGS. 12 and 13 show a wallet packages. - The wallet package can be arranged with blister sheets secured face down on a panel, or face up. The face down embodiments are illustrated first.
-
FIG. 1 illustrates an embodiment of the invention utilizingwallet package 10 with four panels and three folds. A wide variety of fold sequences, layouts of panels, and numbers of panels can be used. Each illustrated exemplary panel has a first and second side (sides a and b, respectively). The first sides, 1 a, 2 a, 3 a and 4 a can be seen inFIG. 1A .Panel side 4 a has cutouts 11 (as exemplified, 2 rows of 4) The dotted box illustrates whereblister sheet 20, exemplified inFIG. 1B , is fitted.Blister sheet 20, turned over from the orientation illustrated, is fitted corner a to corner a, corner b to corner b, and so on, such that protrusions 22 (seeFIG. 1C ) fit intocutouts 11. - The blister sheet has one or more backing layers of sufficient strength that a dosage unit (i) cannot be conveniently pushed through the backing layer(s) without peeling off some or all of at least one of the backing layers or (ii) can only be pushed through with a force sufficient to provide child-resistance. For example, as exemplified in the cutaway of
FIG. 1C , the backing layers are made up of avapor barrier 21B (e.g., foil), and a reinforcinglayer 21C. Reinforcinglayer 21C can be layered against (such as adhered to)vapor barrier 21B, and can be peeled away fromouter layer 21A with or without all or part of theunderlying vapor barrier 21B. As will be understood in the art, in many cases only a portion of the area of reinforcinglayer 21C under a givenprotrusion 22 may need to be peeled to make it convenient to pushdosage unit 23 through the remaining backing layer structure. Outer layer 21 may or may not be transparent. - The layers (of the backing layers) adapted to be peeled away are typically strong enough to not tear (except along perforations, cuts or other deliberate weakened structures) during the peeling process. These layers can be, for example, polymer-reinforced paper, polymer sheets, and the like.
- The dual-arrowed arcs shown in
FIG. 1A , show illustrative fold directions. Illustrated fold 1D shows the fold of first side 1 a, ontofirst side 2 a, to yield the folded view ofFIG. 1D , where, as a result of the fold,second side 1 b is face up. InFIG. 1D ,blister sheet 20 is shown adhered in place onfirst side 4 a, with its back side showing. The dark arrows illustrate positions for barrier access devices (defined below).Lines 24 can be perforations, cuts, or other weakenings in the reinforcinglayer 21C, such that any given blister barrier (defined below) is isolated to one dosage unit (or designated set of dosage units if appropriate). Or,lines 24 can simply be boundaries between areas (again blister barriers) corresponding to dosage units (or sets of dosage units), and may have no physical presence on the blister sheet. Perforations can be through all layers of the blister sheet. Blister access devices, if present, can be located in any number of locations on the blister sheet. Perforations or cuts oflines 24, for example, can be deeper at the barrier access devices to facilitate manual access. - First and second
reusable closures blister sheet 20. -
Fold 1E yields the view ofFIG. 1E , wheresecond side 4 b can include compliance assistance printing. First and secondreusable closures wallet package 10 to be releasably held in a closed position.Fold 1F yields the view ofFIG. 1F , wheresecond side 2 b includes printing of illustrative marketing information. The reusable closures (e.g., 12A, 12B, 17A, 17B) can be of a wide variety known in the art, including reclosable glue seals (in which case one of closures of a pair {12A or 12B, or 17A or 17B} is simply wallet material suitable for accepting the glue seal provided by the other closure), hook and loop closures such as Velcro™, snaps, buttons, tuck and fit, and the like. Closures can be tapes or straps that partially or fully wrap around the folded wallet package. For example, closures can be label closures (as known in the art) which can be reclosable and/or tamper evident. -
FIG. 2 shows an illustrative wallet package 30 withcutouts 31, that uses an alternative fold pattern (from among the many available). - The various panels of a wallet package can be used to provide printing with marketing, dosage, warnings, and the like. Booklets can be securely or releasably affixed to a panel. For example, a product insert, such as one required by a regulatory agency, can be so secured or affixed. Or, secured or affixed can be a booklet that provides compliance assistance, such as a generic calendar with checkoffs, or the like.
- It will be recognized that a wide variety of layouts of dosage units can be used in a blister sheet in a wallet package of the invention.
- For simplicity, a number of additional embodiments shall be illustrated in a 4-panel layout similar to that of
wallet package 10, with at least the first fold previously illustrated (fold 1D) already made. -
FIG. 3 shows an exemplary embodiment of awallet package 50 in whichblister sheet 60 can, in part, be folded away from panel 4, for example along optional hinges 65, thereby allowing greater manual access to the barrier access devices.FIG. 3B shows the two illustratedhinges 65 being used, andFIG. 3C shows just one such hinge engaged. In the absence of hinge structure, the dosage units can still be drawn away from panel 4.Protrusions 62 are illustrated as protruding through panel 4, though this can vary with embodiments. The blister sheet can be secured to panel 4 at, for example,contact surface 66. Securing can be by a number of methods, such as adhesive methods, stitching, stapling, riveting, or the like. Optional closure-facilitatingarea 5 illustrates extra spine material used to facilitate one illustrative pattern for folding the panels. Ifpanel 4 b provides compliance assistance printing, then the presence or absence of dosage units aligned with the compliance information can be apparent by looking through the cutouts. - By pulling the dosage units away from panel 4, the child-resistant opening mechanism can be more readily accessed. For example, blister access devices (defined below) located along an outer edge (pulled away from panel 4) can be accessed and engaged more easily. If a scissors or the like are needed to initiate a tear, pulling away allows access for a cut, and for any subsequent tear. Or, perforations can allow individual dosage units (or sets of dosage units) to be torn off, as facilitated by pulling away form panel 4, and then the child-resistant opening mechanism can be operated.
-
FIG. 4 shows one of many other folding sequences or patterns forwallet package 70, which is otherwise analogous to wallet package 50 (withfolds 85 and protrusions 82). Fold A, in this exemplification, is conducted before fold B. - Hinges, such as hinges 65 or 85, can be, for example, fold lines, where folding can be facilitated by methods known in the art, such as perforation along the fold line, compression along the fold line, heat with compression, pre-folding, or the like. The hinges can be designed to bias, to some extent, the blister pack tending to return to a flat aspect (ignoring the protrusions), so as to facilitate closing the wallet package.
-
FIG. 5 shows awallet package 90 in which thecontact surface 106 is to one side of the blister sheet, andoptional hinge 105 is on the same side. The contact surface can be on any side, such that the can pulled up from the right (as here), left, top or bottom (or still other orientations depending upon the blister sheet geometry, and the like). The hinge can be formed for example by wallet panel material, such as folds in the wallet panel. For example, supposing thatcontact surface 106 is on the left, top or bottom, a portion of wallet panel can extend to the corresponding left, top or bottom, connected by a hinge (such as a crease). The extended portion can fold over, and be adhered to, the contact surface, in which case theblister sheet 100 need not be hinged—while preserving all the function of wallet package 90 (or similar designs such as wallet package 230). -
Lines Italicized numbers 1 through 8 illustrate an optional order of usage for the dosage units. After dosage units 1-4 have been used, in some embodiments line 104B allows the used portion of the blister sheet to be torn away, to provide greater access to the barrier access devices for dosage units 5-8. It will be recognized that the same multiple rows, and tearing away used rows, can be used with butterfly designs such as found inFIG. 3 . -
Shaded areas -
FIG. 6 illustrates that nonlinear design elements can be incorporated into the presentation of dosage forms (wallet package 110, hinges 125,lines 124, protrusions 122). -
FIG. 7 illustrateswallet package 130, withlines 144. Theblister sheet 140 can be secured over various areas, such ascontact surface 146A,contact surface 146B, orcontact surface 146C. Even if the secured area is relatively close to the barrier access devices, some separation allows more room for a users' fingers to manipulate the barrier access devices, with less interference from panel 4. - Similar embodiments to those described above, but with the dosage units oriented upwards, are shown in
FIGS. 8A, 8B , 9, 10 and 11. InFIG. 8A and 8B ,wallet package 210 hasblister sheet 220,optional hinge 225,contact surface 226,protrusions 222 andlines 224. InFIG. 9 ,wallet package 230 hasblister sheet 240,optional hinge 245,contact surface 246, and optional reclosable glue seals 248A, 248B.FIG. 10 illustrateswallet package 250. Theblister sheet 260 can be secured over various areas, such ascontact surface 266A,contact surface 266B, orcontact surface 266C. InFIG. 11 ,wallet package 270 is folded in one of the many alternative fold patterns. -
FIG. 12 illustrates a prior art design in which a blister sheet is adhered betweenpanel 3 and panel 4, such that there is no access to the back side of the blister sheet. - Definitions
- The following terms shall have, for the purposes of this application, the respective meanings set forth below.
- Dosage Form
- The term “dosage form” includes any solid form that is sufficiently self-cohesive to be presented in a blister sheet, and includes an amount of a material for delivery to a subject (such as by ingestion, as a suppository, as a lozenge, as a mucosal adherent, or the like).
- Blister Barrier
- A “blister barrier” is a covering for one or more dosage units of which at least a portion must be peeled, torn, cut, or pushed through to allow a user of a dosage unit to conveniently, but in a child-resistant manner, access the dosage unit. Any blister barrier usable to provide child resistance in a blister sheet can be used in the invention. Child resistance is as recognized in the pharmaceutical industry (e.g., F1, F2, F3 levels of child resistance).
- Blister Access Device
- A “blister access device” is any device used in a child-resistant blister sheet. Blister access devices can include, for example, a pull tab, a pull tab access by tearing perforations to allow peeling to reveal the pull tab, notches to facilitate tearing, and the like.
- Wallet Panels
- A “wallet panel” is any panel made of a moderately stiff material allowing a wallet package to be reusably opened and closed over a useful lifetime. It will be recognized that, depending on dimension, the support provided by adhered components, and the like, that the stiffness required for making a useful wallet package can vary.
- Subject
- A “subject” is any animal, including a human, for which it may be appropriate to delivery a dosage form.
- Publications and references, including but not limited to patents and patent applications, cited in this specification are herein incorporated by reference in their entirety in the entire portion cited as if each individual publication or reference were specifically and individually indicated to be incorporated by reference herein as being fully set forth. Any patent application to which this application claims priority is also incorporated by reference herein in the manner described above for publications and references.
- While this invention has been described with an emphasis upon preferred embodiments, it will be obvious to those of ordinary skill in the art that variations in the preferred devices and methods may be used and that it is intended that the invention may be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications encompassed within the spirit and scope of the invention as defined by the claims that follow.
Claims (12)
1. A wallet package for presenting blister sheets comprising:
a first wallet panel with a width and height;
a blister sheet comprising dosage forms enclosed between a first side material and a second side material, the second side material having one or more blister barriers, wherein the blister sheet is secured to the first wallet panel such that (i) the dosage forms and the corresponding area of the blister barrier(s) can nonetheless be pulled away from the first wallet panel, or (ii) an edge of the blister sheet can be pulled sufficiently away from the first wallet panel so that blister access devices for said blister barrier(s) can be accessed; and
additional wallet panels with a width and height hingably connected, among themselves and the first wallet panel, such that when folded to a fold position a resulting width and height of the folded wallet package is about the width and height of a largest said wallet panel,
wherein the wallet package can be reversibly folded to the fold position to cover the blister sheet, and reversibly unfolded to uncover the blister sheet.
2. The wallet package of claim 1 , wherein one portion of the blister sheet is secured to the first wallet panel, and a second portion comprises barrier access device(s) and is not secured to the first wallet panel.
3. The wallet package of claim 2 , wherein the first portion is close to, but separate from, the barrier access device(s), the separation facilitating a user's fingers to engage the barrier access devices
4. The wallet package of claim 2 , wherein the blister sheet has a third portion comprising barrier access device(s) and is not secured to the first wallet panel, wherein the second and third portions are separated by the first portion.
5. The wallet package of claim 1 , wherein one portion of the blister sheet is secured to the first wallet panel, and a second portion comprises dosage forms and barrier access device(s) and is not secured to the first wallet panel.
6. The wallet package of claim 5 , wherein the first and second portions of the blister sheet are hingably connected.
7. The wallet package of claim 6 , comprising perforations or other tear-facilitations so that portions of the blister sheet corresponding to the blister barrier(s) can be serially removed.
8. The wallet package of claim 5 , comprising perforations or other tear-facilitations so that portions of the blister sheet corresponding to the blister barrier(s) can be serially removed.
9. The wallet package of claim 5 , wherein the blister sheet has a third portion comprising dosage forms and barrier access device(s), and is not secured to the first wallet panel, wherein the second and third portions are separated by the first portion.
10. The wallet package of claim 9 , wherein the first and second portions of the blister sheet, and the first and third portions of the blister sheet, are hingably connected.
11. The wallet package of claim 10 , comprising perforations or other tear-facilitations so that portions of the blister sheet corresponding to the blister barrier(s) can be serially removed.
12. The wallet package of claim 9 , comprising perforations or other tear-facilitations so that portions of the blister sheet corresponding to the blister barrier(s) can be serially removed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/688,966 US20070227931A1 (en) | 2006-03-21 | 2007-03-21 | Child-Resistant Wallet Package for Dosage Forms |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78452506P | 2006-03-21 | 2006-03-21 | |
US11/688,966 US20070227931A1 (en) | 2006-03-21 | 2007-03-21 | Child-Resistant Wallet Package for Dosage Forms |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070227931A1 true US20070227931A1 (en) | 2007-10-04 |
Family
ID=38557234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/688,966 Abandoned US20070227931A1 (en) | 2006-03-21 | 2007-03-21 | Child-Resistant Wallet Package for Dosage Forms |
Country Status (1)
Country | Link |
---|---|
US (1) | US20070227931A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010011704A1 (en) * | 2008-07-22 | 2010-01-28 | Meadwestvaco Corporation | Integrated closure feature for packaging system |
US20100065459A1 (en) * | 2008-09-17 | 2010-03-18 | Steven Tsao | Safe packaging container |
US20110011875A1 (en) * | 2008-03-14 | 2011-01-20 | Meadwestvaco Corporation | Container for housing a tray or blister pack |
US20110127320A1 (en) * | 2008-07-31 | 2011-06-02 | Meadwestvaco Corporation | Container for housing a tray or blister pack |
US20120261275A1 (en) * | 2009-11-06 | 2012-10-18 | Derek Intini | Child resistant package with floating panel |
US8678189B2 (en) | 2011-11-03 | 2014-03-25 | Berlin Packaging, Llc | Box type container holder for medication cards |
US8708149B2 (en) | 2011-11-03 | 2014-04-29 | Berlin Packaging, Llc | Flip container for blister card medication holders |
US9173812B2 (en) * | 2011-03-17 | 2015-11-03 | Sanofi | Packaging for unit pharmaceutical products |
US20160120748A1 (en) * | 2014-11-03 | 2016-05-05 | Multi Packaging Solutions Uk Limited | Packaging |
WO2022194941A1 (en) * | 2021-03-17 | 2022-09-22 | Actelion Pharmaceuticals Ltd | Pharmaceutical dosage system |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4340141A (en) * | 1981-02-23 | 1982-07-20 | E. I. Du Pont De Nemours And Company | Unit dose drug control package |
US4974729A (en) * | 1989-04-17 | 1990-12-04 | Bristol-Myers Squibb Company | Reminder system for taking medication |
US5046618A (en) * | 1990-11-19 | 1991-09-10 | R. P. Scherer Corporation | Child-resistant blister pack |
US6155423A (en) * | 1997-04-01 | 2000-12-05 | Cima Labs Inc. | Blister package and packaged tablet |
US6219997B1 (en) * | 1996-07-01 | 2001-04-24 | Astrazeneca Ab | Blister pack |
US6253920B1 (en) * | 1995-06-30 | 2001-07-03 | Astrazeneca Ab | Blister pack |
US6394275B1 (en) * | 2000-10-11 | 2002-05-28 | F. M. Howell & Company | Child resistant package |
US20030213721A1 (en) * | 2002-05-14 | 2003-11-20 | Marty Jones | Peel away tab child resistant package |
US6659280B2 (en) * | 2002-02-04 | 2003-12-09 | Howell Packaging, Division Of Fm Howell & Co. | Multi-layered child resistant blister |
US20040026293A1 (en) * | 2000-08-29 | 2004-02-12 | David Hughes | Carded blister pack |
US20040182739A1 (en) * | 2003-03-20 | 2004-09-23 | Williams-Hartman Wade Everelle | Child-resistant and senior-friendly blister card package |
US20040188312A1 (en) * | 2003-03-28 | 2004-09-30 | Shorewood Packaging Corporation | 024340 Childproof blister pack card |
US20040188315A1 (en) * | 2003-03-31 | 2004-09-30 | Makoto Morita | Case for a press-through package |
US20050145532A1 (en) * | 1999-06-02 | 2005-07-07 | Peter Kancsar | Child-resistant packaging for tablets |
US20050274643A1 (en) * | 2004-06-11 | 2005-12-15 | William Arnold | Child resistant product dispenser |
US20060289328A1 (en) * | 2005-06-27 | 2006-12-28 | Christopher Hession | Child-Resistant Blister Package |
-
2007
- 2007-03-21 US US11/688,966 patent/US20070227931A1/en not_active Abandoned
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4340141A (en) * | 1981-02-23 | 1982-07-20 | E. I. Du Pont De Nemours And Company | Unit dose drug control package |
US4974729A (en) * | 1989-04-17 | 1990-12-04 | Bristol-Myers Squibb Company | Reminder system for taking medication |
US5046618A (en) * | 1990-11-19 | 1991-09-10 | R. P. Scherer Corporation | Child-resistant blister pack |
US6253920B1 (en) * | 1995-06-30 | 2001-07-03 | Astrazeneca Ab | Blister pack |
US6219997B1 (en) * | 1996-07-01 | 2001-04-24 | Astrazeneca Ab | Blister pack |
US6155423A (en) * | 1997-04-01 | 2000-12-05 | Cima Labs Inc. | Blister package and packaged tablet |
US20050145532A1 (en) * | 1999-06-02 | 2005-07-07 | Peter Kancsar | Child-resistant packaging for tablets |
US20040026293A1 (en) * | 2000-08-29 | 2004-02-12 | David Hughes | Carded blister pack |
US6394275B1 (en) * | 2000-10-11 | 2002-05-28 | F. M. Howell & Company | Child resistant package |
US6659280B2 (en) * | 2002-02-04 | 2003-12-09 | Howell Packaging, Division Of Fm Howell & Co. | Multi-layered child resistant blister |
US20030213721A1 (en) * | 2002-05-14 | 2003-11-20 | Marty Jones | Peel away tab child resistant package |
US20040182739A1 (en) * | 2003-03-20 | 2004-09-23 | Williams-Hartman Wade Everelle | Child-resistant and senior-friendly blister card package |
US20040188312A1 (en) * | 2003-03-28 | 2004-09-30 | Shorewood Packaging Corporation | 024340 Childproof blister pack card |
US20040188315A1 (en) * | 2003-03-31 | 2004-09-30 | Makoto Morita | Case for a press-through package |
US20050274643A1 (en) * | 2004-06-11 | 2005-12-15 | William Arnold | Child resistant product dispenser |
US20060289328A1 (en) * | 2005-06-27 | 2006-12-28 | Christopher Hession | Child-Resistant Blister Package |
US7401702B2 (en) * | 2005-06-27 | 2008-07-22 | Meadwestvaco Corporation | Child-resistant blister package |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110011875A1 (en) * | 2008-03-14 | 2011-01-20 | Meadwestvaco Corporation | Container for housing a tray or blister pack |
US8312993B2 (en) | 2008-03-14 | 2012-11-20 | Meadwestvaco Corporation | Container for housing a tray or blister pack |
US20110114527A1 (en) * | 2008-07-22 | 2011-05-19 | Meadwestvaco Corporation | Integrated closure feature for packaging system |
WO2010011704A1 (en) * | 2008-07-22 | 2010-01-28 | Meadwestvaco Corporation | Integrated closure feature for packaging system |
US8701889B2 (en) | 2008-07-31 | 2014-04-22 | Meadwestvaco Corporation | Container for housing a tray or blister pack |
US20110127320A1 (en) * | 2008-07-31 | 2011-06-02 | Meadwestvaco Corporation | Container for housing a tray or blister pack |
US9180068B2 (en) | 2008-07-31 | 2015-11-10 | Westrock Mwv, Llc | Container for housing a tray or blister pack |
US20100065459A1 (en) * | 2008-09-17 | 2010-03-18 | Steven Tsao | Safe packaging container |
US7959004B2 (en) * | 2008-09-17 | 2011-06-14 | Steven Tsao | Safe packaging container |
US20120261275A1 (en) * | 2009-11-06 | 2012-10-18 | Derek Intini | Child resistant package with floating panel |
US9173812B2 (en) * | 2011-03-17 | 2015-11-03 | Sanofi | Packaging for unit pharmaceutical products |
US8708149B2 (en) | 2011-11-03 | 2014-04-29 | Berlin Packaging, Llc | Flip container for blister card medication holders |
US8689978B2 (en) | 2011-11-03 | 2014-04-08 | Berlin Packaging, Llc | Hinged container holder for medication cards |
US8678189B2 (en) | 2011-11-03 | 2014-03-25 | Berlin Packaging, Llc | Box type container holder for medication cards |
US20160120748A1 (en) * | 2014-11-03 | 2016-05-05 | Multi Packaging Solutions Uk Limited | Packaging |
WO2022194941A1 (en) * | 2021-03-17 | 2022-09-22 | Actelion Pharmaceuticals Ltd | Pharmaceutical dosage system |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070227931A1 (en) | Child-Resistant Wallet Package for Dosage Forms | |
JP4741515B2 (en) | Blister and package system | |
JP4199462B2 (en) | Unit dose packaging system with external pocket function | |
US7563468B2 (en) | Chewing gum packages with gum disposal accommodations | |
EP2080716B1 (en) | Child-resistant, senior-friendly carded package and method of assembly | |
EP2305575B1 (en) | Child-resistant, senior-friendly package having a squeeze-release mechanism | |
JP4165735B2 (en) | Child resistance and senior friendly unit dose packaging system | |
US20140103100A1 (en) | Fold and pull easy open paperboard package | |
US10858163B2 (en) | Child-resistant package assembly | |
US10206851B1 (en) | Child-resistant, senior-friendly package | |
JP2007050933A (en) | Blister package with tear-open notch opening | |
JP2008543693A (en) | Blister pack that children can not mischief | |
WO2016133797A1 (en) | Reclosable carton with carrying handle | |
CA2391549C (en) | Unit dose packaging system with molded locking feature | |
EP3015396B1 (en) | Packaging | |
AU2001269324B2 (en) | Folded sheet product | |
GB2543922B (en) | Tamper evident package assembly and associated blank | |
AU2001269324A1 (en) | Folded sheet product | |
JP2005104548A (en) | Paper-made storage box | |
MXPA06007802A (en) | Blister and package system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |